The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

The French drugmaker said the vaccine it agreed to develop with Johnson & Johnson a year ago was “not sufficiently effective.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Fate ...

Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an ...

Deal-starved banks lined up to make concessions to get a slice of Europe’s biggest buyout debt deal last year. They also put ...

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies ...

MC: There is no old or new model, but there is old school thinking and open school thinking. We are clearly conscious of this within Sanofi and we truly believe that we will overcome the future ...

"Sanofi's collaboration with Exscientia aims to transform how we discover and develop new small molecule medicines for cancer and immune-mediated diseases," said the pharma group's chief ...

The upcoming series serves as an unofficial fourth season to Netflix's pre-MCU Daredevil series, which saw Jon Bernthal kick ...

Sanofi’s track record of creating effective solutions for people living with diabetes has lead to the development of the BGStarTM, a blood glucose monitoring device with the tools and a support ...

The Indian subsidiary of French pharma major Sanofi (Euronext: SAN) has received marketing authorization for Rezurock (belumosudil tablets) in India. Rezurock represents a new, best-in-class treatment ...